Outset Medical to Host Patient and Physician Webinar for Investment Professionals
May 12 2022 - 4:05PM
Business Wire
Discussion to focus on Tablo® Hemodialysis
System and Home Dialysis
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company pioneering a first-of-its-kind technology to
reduce the cost and complexity of dialysis, today announced that it
will host a virtual patient and physician webinar on its Tablo®
Hemodialysis System for use in home dialysis on Wednesday, June 1,
2022 at 1:00pm PT / 4:00pm ET.
The live webinar, intended for investment professionals, will
feature a panel discussion moderated by Michael Aragon, MD,
Outset’s Chief Medical Officer, between Tablo home dialysis
patients and Varshi Broumand, MD, MHA, FACP, FASN, Dialysis Medical
Director at CHRISTUS Santa Rosa Health System and nephrologist at
South Texas Renal Care Group. The discussion will focus on the
patient care journey to home dialysis and each patient’s experience
dialyzing at home with Tablo.
A live question and answer session will follow. To register for
the event, please click here.
A live and archived webcast of the webinar will be available on
the “Investors” section of the Outset website at
https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220512005685/en/
Jim Mazzola Vice President, Investor Relations
jmazzola@outsetmedical.com
Brian Johnston Gilmartin Group (332) 895-3222
investors@outsetmedical.com
Outset Medical (NASDAQ:OM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Outset Medical (NASDAQ:OM)
Historical Stock Chart
From Apr 2023 to Apr 2024
